A

Alto Neuroscience

AI-driven precision psychiatric drug development

Clinical Development Program Lead

Biology & BiotechUpdated on Nov 14
Full-timeMountain View, CA, USA$280k - $310k

About the Job

Requirements

  • M.D., Ph.D., or equivalent advanced degree in a relevant discipline.
  • At least 5 years of clinical development experience within the biopharma industry, including direct responsibility for Phase 1–3 study execution.
  • A proven track record designing and executing clinical programs in psychiatry or other relevant indications.
  • Prior involvement in FDA or EMA meetings supporting clinical development.
  • Deep understanding of clinical trial operations, Good Clinical Practice (GCP), and regulatory expectations for pivotal programs.
  • Ability to synthesize clinical and operational perspectives into decisive program leadership.
  • Communication, collaboration, and leadership skills.
  • Comfort working in a fast-paced, entrepreneurial environment requiring strategic and hands-on engagement.

Responsibilities

  • Serve as the overall program lead, accountable for end-to-end planning, execution, and delivery of key clinical study milestones through New Drug Application (NDA) submission.
  • Partner with Program Management to align and execute across the cross-functional program team, including developing and maintaining integrated project plans, timelines, and budgets; proactively identifying risks; and implementing mitigation strategies.
  • Ensure operational excellence and quality across program activities, including oversight of external vendors and partners.
  • Collaborate with the Chief Medical Officer (CMO) and senior leadership to align development activities with corporate objectives and portfolio priorities.
  • Represent the program at internal governance forums and, as appropriate, in interactions with partners or external stakeholders.
  • Provide clinical leadership and oversight to ensure scientific rigor, patient safety, and data integrity. If an M.D., provide medical oversight; otherwise, work closely with the designated medical monitor.
  • Oversee clinical review of safety, efficacy, and emerging biomarker data.
  • Lead study review committees and participate in interpreting interim and final study results.
  • Partner with the CMO and cross-functional experts to refine study designs and long-term safety strategies.
  • Support interactions with health authorities such as the Food and Drug Administration (FDA) and European Medicines Agency (EMA), including preparation of briefing packages and regulatory submissions.
  • Engage with clinical investigators, key opinion leaders, and advisory boards to ensure study alignment with medical and scientific standards.
  • Collaborate with Clinical Operations, Data Management, and Data Science to ensure high-quality trial conduct, timely database locks, and accurate data reporting.
  • Ensure compliance with GCP, protocol requirements, and regulatory standards across all study sites.
  • Drive internal readiness and alignment for key study milestones and data readouts.
  • Provide clinical leadership during analysis, interpretation, and communication of results, including publications, scientific meetings, and regulatory submissions.
  • Lead or contribute to drafting and reviewing key regulatory documents, including study reports, briefing packages, and NDA components.
  • Partner with Regulatory Affairs, Clinical Operations, and Chemistry, Manufacturing, and Controls (CMC) to ensure readiness for pivotal and registration phases.
  • Support external scientific communication through investigator meetings, advisory boards, and key opinion leader engagement.
  • Provide mentorship and clinical leadership to other team members.
  • Champion a culture of accountability, collaboration, and patient-focused innovation.
  • Operate as a hands-on leader within a nimble, high-performing clinical development team.

Desired Qualifications

  • Experience leading psychiatric or neuroscience development programs.
  • Demonstrated success overseeing late-stage trials and contributing to regulatory submissions such as NDA, supplemental NDA (sNDA), or Marketing Authorisation Application (MAA).
  • Exposure to or interest in biomarker-driven development, including neurophysiologic or digital biomarkers.

About the Company

Alto Neuroscience

AI-driven precision psychiatric drug development

Alto Neuroscience develops AI-guided precision psychiatric drugs. It uses brain biomarkers and clinical data to match patients to specific Alto drug candidates. The approach aims to improve outcomes with personalized, biology-based selection and relies on ongoing clinical trials and regulatory approval. The business model centers on developing and commercializing these drugs for the psychiatric market once approved.

Company size
51-200
Company stage
IPO
Headquarters
Los Altos, CA
Founded
2019

Recently Posted Jobs

Explore more opportunities at Alto Neuroscience

See more jobs